Clinical Outcomes in Adult Patients with Aplastic Anemia- a single institution experience
|
Aug 2017
|
Am J Hematol
|
aplastic anemia
|
Defeating anaemia in myelodysplastic syndromes: another step forward
|
Sep 2017
|
Lancet Oncol
|
myelodysplastic syndromes (MDS)
|
Differences in genomic patterns and clinical outcomes between African-American and White patients with myelodysplastic syndromes
|
Sep 2017
|
Blood Cancer J
|
myelodysplastic syndromes (MDS)
|
Luspatercept for the treatment of anaemia in patients with lower-risk myelodysplastic syndromes (PACE-MDS): a multicentre, open-label phase 2 dose-finding study with long-term extension study
|
Sep 2017
|
Lancet Oncol
|
myelodysplastic syndromes (MDS)
|
Ex vivo T-cell depletion in allogeneic hematopoietic stem cell transplant: past, present and future
|
Sep 2017
|
Bone Marrow Transplantation
|
graft versus host disease (GVHD)
|
Targeted next-generation sequencing in myelodysplastic syndromes and prognostic interaction between mutations and IPSS-R
|
Sep 2017
|
Am J Hematol
|
myelodysplastic syndromes (MDS)
|
Origins of myelodysplastic syndromes after aplastic anemia
|
Sep 2017
|
Blood
|
aplastic anemia
|
Aplastic anemia in two consecutive pregnancies: obstetric and anesthetic management
|
Sep 2017
|
Int J Obstet Anesth
|
aplastic anemia
|
Computational Modeling and Treatment Identification in the Myelodysplastic Syndromes
|
Sep 2017
|
Curr Hematol Malig Rep
|
myelodysplastic syndromes (MDS)
|
Optimizing the use of hypomethylating agents in myelodysplastic syndromes: Selecting the candidate, predicting the response, and enhancing the activity
|
Sep 2017
|
Semin Hematol
|
myelodysplastic syndromes (MDS)
|